Goodwin Procter LLP advised Abingworth on the deal.Abingworth announced the formation of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8), which closed at $465…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
